Brief: Ryvu Therapeutics To Get EUR 8 Mln Of Financing From EIB
June 18 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SAID ON MONDAY IT FULFILLED CONDITIONS FOR DISBURSEMENT OF
TRANCHE B OF FINANCING FROM EUROPEAN INVESTMENT BANK (EIB)
* FOLLOWING SAID FULFILMENT COMPANY EXPECT TO GET EUR 8.0
MLN ON
JUNE 25
* COMPANY IS REQUIRED TO REPAY TRANCHE B BY JUNE 25, 2029
Source text for Workspace: urn:newsml:reuters.com:*:nEM2lZmCCa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys